MCL1 and Miyoshi myopathy: have shown the importance of MCL-1 in MM cell survival and proposed combining carfilzomib (which increases Noxa mRNA expression) with TG02 (decreases MCL-1 protein) as a strategy for dual MCL-1 inhibition (20).